Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04610684
Title Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jeffrey Clarke
Indications

lung small cell carcinoma

Therapies

Atezolizumab

Atezolizumab + Carboplatin + Etoposide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.